ADM
Catalysts
Key Risks
The Opportunity
ADM is a 120-year-old company that sits at the center of the global food supply chain. Think of them as the plumbing of agriculture - they buy crops from farmers, ship them around the world, and process them into ingredients that end up in everything from cooking oil to animal feed to ethanol fuel. They are one of only four companies in the world with the infrastructure to do this at massive scale.
The stock has had a rough couple of years. Crop prices spiked during COVID and the Ukraine war, giving ADM a huge profit windfall in 2022-2023. When prices came back down, profits collapsed - earnings fell 76% from their peak. On top of that, the SEC caught ADM inflating the numbers in their nutrition business and fined them $40 million. The stock dropped from the mid-$90s to the low $50s. But now earnings are recovering sharply - last quarter was dramatically better than expected, and the company just raised its full-year outlook.
The case for buying ADM is that you are getting a dominant global food infrastructure business at a reasonable price during a recovery. The company is cutting costs aggressively, selling off underperforming businesses, and benefiting from government policies that promote biofuels. If crush margins (the profit they make from processing soybeans) stay healthy and biofuel subsidies continue, earnings could normalize around $5 per share, putting the stock at roughly 15 times earnings - not expensive for a Dividend Aristocrat.
The main thing that could go wrong is that a massive lawsuit over alleged ethanol market manipulation could result in damages of $500 million to $2 billion - not enough to sink the company, but enough to take a real bite out of shareholder value. On top of that, their biggest competitor Bunge just merged with Viterra to become even larger, which could squeeze ADM's margins over time. And the accounting scandal, while resolved with regulators, has left lingering class action lawsuits from investors. The stock has already rallied 53% over the past year, so a lot of the recovery is arguably already priced in.
Breakdown
ADM's balance sheet as of Q2 2026 shows total assets of $53.53B against total liabilities of $29.66B, yielding book equity of $23.58B or $48.93/share. However, estimated fair value diverges from book in several key areas. First, ADM carries significant goodwill and intangible assets from its Nutrition segment acquisitions - and the SEC settlement confirmed that Nutrition segment performance was materially inflated in 2021-2022 [SEC Press Release, Jan 2026], raising questions about whether those intangibles were impaired more than recognized.
Second, ADM's inventory and commodity positions ($15-20B range historically) are marked near fair value given active commodity markets, so minimal adjustment is needed there. Third, the investment in Wilmar International (a publicly traded Asian agribusiness) provides a liquid, mark-to-market asset that may carry value above its equity-method book. On the liability side, total debt stands at roughly $8.01B ($1.56B current + $6.45B long-term), with a D/E ratio of just 0.34 - conservative for the industry.
Bunge by comparison carries D/E of 0.96. The current ratio of 1.39 is adequate though the quick ratio of 0.86 reveals reliance on inventory to cover near-term obligations - normal for an ag commodity processor. Cash of $1.06B is thin relative to the $80B revenue base, yielding a cash ratio of just 0.05.
Net-net, tangible book is probably in the $42-48/share range after discounting Nutrition-related intangibles, providing a reasonable floor. The balance sheet is healthy but not fortress-grade.
ADM generated $1.68B in free cash flow over the trailing period, translating to $3.48/share - modest relative to the $76.59 stock price (P/FCF of 22x). The dividend consumes the vast majority of available cash: at $2.08/share annually (2.71% yield), the payout ratio stands at a strained 91.59% on TTM EPS of $2.23. This is a cyclical trough issue - as FY2025 delivered only $2.23 in EPS vs. $7.71 in FY2022. With guidance now raised to $5.15-$5.60 for FY2026 [ADM Investor Relations, 2026], the payout ratio normalizes to roughly 37-40%, which is sustainable.
ADM has been an aggressive repurchaser, reducing shares from approximately 555M in 2020 to 482M currently - a 13% reduction over six years, adding meaningful per-share value. The $500-$750M cost savings program delivered $200M in 2025 and is on track [Food Dive, 2025]. ADM is also pursuing ~$2B in divestitures including the ADMIS futures brokerage [Food Dive, 2025], which should generate cash for debt reduction or shareholder returns.
Capital allocation has historically favored buybacks and dividends over empire-building, with the notable exception of the problematic Nutrition segment acquisitions. The 53-year consecutive dividend increase streak [The Top 2 Consumer Staples Stocks, Mar 2026] demonstrates commitment to the payout, but at $2.08/share the absolute dollar amount is modest enough to sustain even in trough years.
ADM's financial history reveals a classic commodity processor pattern: revenue and earnings swing with crop prices and crush margins, making consistency difficult to evaluate on absolute numbers alone. Revenue peaked at $101.56B in 2022 and has declined to $80.27B in FY2025 as commodity prices normalized - a 21% decline. More concerning is the earnings trajectory: net income fell from $4.37B (2022) to $3.47B (2023) to $1.78B (2024) to just $1.07B (2025) - a 76% decline peak-to-trough.
EPS followed: $7.71 to $6.43 to $3.65 to $2.23. Operating margins compressed from 4.1% (2022) to 1.2% (2025). However, the most recent quarter (Q2 2026) shows a sharp inflection: revenue of $22.68B (+7.1% YoY), operating income of $896M, and EPS of $1.87 - the best quarter in over a year. Crushing profit surged to $363M from $33M a year earlier [Yahoo Finance, Aug 2026].
Over the longer 10-year view, ADM has compounded EPS from $2.16 (2016) to a TTM of $3.67, roughly 5.4% annualized - modest but punctuated by a massive 2021-2023 super-cycle. Management repeatedly beat consensus estimates in recent quarters: Q2 2026 actual $1.87 vs est $1.49, Q1 2026 $0.71 vs $0.641, Q4 2025 $0.92 vs $0.849. This pattern of under-promising and over-delivering since the accounting scandal cleanup is a positive signal, though the earlier Nutrition segment fraud casts a shadow over pre-2024 reported results [SEC Press Release, Jan 2026].
ADM raised full-year 2026 guidance to $5.15-$5.60 adjusted EPS, implying a sharp recovery from 2025's $2.23 [GuruFocus Q2 2026 Earnings Highlights, Aug 2026]. The midpoint of $5.38 would represent 141% growth - but this is recovery to a more normalized level rather than organic growth. Analyst consensus projects 15.37% annualized EPS growth over the next five years, which appears aggressive for a mature commodity processor.
A more realistic sustainable growth rate is 5-8%, driven by: (1) volume growth from global protein demand and biofuel mandates, (2) the $500-$750M cost savings program contributing $100-150M annually to the bottom line, (3) share buybacks adding 2-3% per year to per-share growth, and (4) the 45Z biofuel tax credit providing ~$250M in 2026 benefits [GuruFocus Q2 2026 Earnings, Aug 2026]. The reverse DCF implies a 7.7% growth rate at current prices, which is more plausible than the 15.4% analyst estimate. Key risk to forward estimates: crush margins are highly cyclical and the Q2 2026 surge may not be sustainable as Bunge-Viterra adds capacity [World-Grain, Jul 2025].
Normalized mid-cycle EPS of $4.50-$5.00 seems reasonable, putting the forward P/E at 15-17x on normalized earnings - roughly fair for the sector. The PEG ratio of 0.97 using analyst estimates suggests fair value, but only if that growth rate materializes.
ADM possesses a narrow moat built on three interlocking advantages: (1) Scale and infrastructure - ADM operates one of the world's largest grain storage, transportation, and processing networks. This physical asset base of elevators, ports, rail, barges, and processing plants would cost tens of billions to replicate and creates meaningful cost advantages in logistics-heavy commodity merchandising. (2) Efficient scale in crushing and processing - ADM is one of only four global players (the ABCD quartet) with the scale to originate, transport, and process agricultural commodities globally, creating a natural oligopoly [UkrAgroConsult, 2024]. (3) Customer relationships and contracts with farmers, food companies, and biofuel producers built over 120+ years. However, the moat is narrowing: the Bunge-Viterra merger created a larger competitor with 56 oilseed crushing plants and ~26% of U.S. soy processing [World-Grain, Jul 2025], and Chinese state-backed Cofco International has grown to 127 million tonnes of grain/oilseed sales, eroding ABCD dominance [UkrAgroConsult, 2024].
Critically, ADM processes commodities - it does not own proprietary brands or technology that command pricing power. Margins are thin (net margin 2.2%) and driven by spread economics, not brand premium. The moat is real but narrow and under competitive pressure.
Management assessment is complicated by the Nutrition segment accounting fraud. CEO Juan Luciano has led ADM since 2015, overseeing both the successful commodity super-cycle performance and the period during which Nutrition segment results were materially inflated in 2021-2022. The SEC settled with ADM for $40M, and former executives Macciocchi and Young were individually charged [SEC Press Release, Jan 2026].
The DOJ dropped its criminal probe [Investigate Midwest, Jan 2026], suggesting the fraud was not systemic but rather isolated to the Nutrition segment. Post-scandal remediation appears genuine: a new Chief Accounting Officer (Carrie Nichol, hired from Cargill) was installed in March 2025 [GuruFocus, 2025], and a new COO (Jeffrey Rowe, former Syngenta CEO) was appointed in August 2026 [GuruFocus, Aug 2026]. These are strong external hires signaling a reset.
On capital allocation, ADM's track record is mixed: the share buyback program has been value-accretive, the 53-year dividend streak is impressive, but the Nutrition segment acquisitions destroyed value. Insider ownership at 0.68% is low, though director stock awards in April 2026 show board alignment. Net insider transactions show -4 (net sales), which is mildly negative.
Institutional ownership at 87.6% provides governance oversight. I cannot assess management integrity through personal interaction, but the measurable actions post-scandal - leadership changes, cost restructuring, portfolio simplification - are constructive.
ADM faces several material risks.
The ethanol market manipulation lawsuit filed by Green Plains and AOT Holding alleges class damages of $500M to over $2B [Ethanol Producer Magazine, 2020; DTN, Jul 2023]. No confirmed resolution was found in current search results. If ADM loses or settles at the high end, the impact on a $37B market cap company would be significant - roughly $4-8/share at the midpoint.
The securities class action survived dismissal in March 2025 and is in discovery [DTN/Progressive Farmer, Mar 2025]; potential exposure is unquantified but likely $200-500M.
ADM's earnings are heavily tied to crop prices, crush spreads, and ethanol margins - all of which are volatile and largely outside management control. The 76% peak-to-trough earnings decline (2022-2025) demonstrates this risk clearly.
The Bunge-Viterra merger creates a larger, more scaled competitor that could pressure margins, especially in U.S. soy processing [World-Grain, Jul 2025].
Biofuel policy (45Z, RVOs) is a major earnings driver - any policy reversal or delay would directly impact the ~$250M tailwind ADM expects in 2026.
ADM's business is geographically diversified but concentrated in commodity processing with thin margins, making it vulnerable to any disruption in the global agricultural supply chain.
ADM operates in the global edible oils, fats, and agricultural processing industry, which is projected to grow at 5-6% CAGR through 2030 [National Law Review, 2025; Coherent Market Insights, 2025]. Structural demand drivers are favorable: population growth, rising protein consumption in Asia, and - crucially - biofuel mandates creating incremental demand for vegetable oils and corn-based ethanol. ADM is the second-largest ABCD trader by revenue and maintains a leading position in U.S. corn processing and ethanol.
The competitive landscape is intensifying: Bunge-Viterra is now larger in oilseed crushing, and Cofco International represents growing Chinese competition [UkrAgroConsult, 2024]. Analyst sentiment is lukewarm with a consensus recommendation of 3.27 (between hold and underperform) and a target price of $77.11 - essentially at the current price. Institutional ownership at 87.6% is stable.
Short interest at 3.68% with a 4.73-day short ratio is moderate - not a crowded short but enough to suggest some bears. The stock has rallied 52.86% over the past year and 35.78% YTD, suggesting much of the recovery is already priced in. No M&A interest in ADM as a target was found; the company is a net seller of assets [Food Dive, 2025].
Social sentiment scores of 5/5 across platforms suggest neutral positioning. The protein ingredients market growing at 7.9% CAGR to $121.5B by 2031 [Protein Ingredients Market Report, Jun 2026] and feed additives market at 6.0% CAGR [Feed Additives Market Report, Mar 2026] provide favorable tailwinds for ADM's nutrition and animal feed businesses.